Tableting Defects

Tableting Defects is a pharmaceutical formulation phenomenon characterized by unintended physical or structural deviations in compressed solid dosage forms that compromise their quality, efficacy, or manufacturability.

9

Publications

272

Citations

35

Authors

11

Institutions

Publications per year

2017–2026

4

Authors

35

  1. DS
    Daniel Skomski

    Merck & Co., Inc., Rahway, NJ, USA (United States), United States

    2 publications · 103 citations

    2

    h-index

  2. MM
    Mike Marsh

    Object Research Systems (Canada), Canada

    2 publications · 103 citations

    2

    h-index

  3. AC
    Antong Chen

    Merck & Co., Inc., Rahway, NJ, USA (United States), United States

    2 publications · 103 citations

    2

    h-index

  4. HX
    Hanmi Xi

    Merck & Co., Inc., Rahway, NJ, USA (United States), United States

    2 publications · 103 citations

    2

    h-index

  5. BS
    Bradley Sorman

    Merck & Co., Inc., Rahway, NJ, USA (United States), United States

    2 publications · 103 citations

    2

    h-index

1–5 of 35

Venues

  1. Journal of Pharmaceutical Sciences

    4 publications · 168 citations

    4

    h-index

  2. International Journal of Pharmaceutics

    2 publications · 36 citations

    1

    h-index

  3. Engineering Failure Analysis

    1 publications · 14 citations

    1

    h-index

  4. Microscopy and Microanalysis

    1 publications · 13 citations

    1

    h-index

  5. Chemical and Pharmaceutical Bulletin

    1 publications · 15 citations

    1

    h-index

1–5